172 related articles for article (PubMed ID: 6142849)
1. [Changes in therapy of duodenal ulcers. The European Gastro-Club 1983 discusses new pathophysiologic and epidemiologic data referring to drug and surgical therapy].
Demling L
Fortschr Med; 1983 Dec; 101(47-48):2195-6. PubMed ID: 6142849
[No Abstract] [Full Text] [Related]
2. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
3. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
4. Treatment of duodenal ulcer.
Eliakim R; Rachmilewitz D
Rev Clin Basic Pharm; 1985; 5(3-4):215-33. PubMed ID: 2881325
[TBL] [Abstract][Full Text] [Related]
5. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
6. [Duodenal peptic ulcer. Medical therapy].
Villalobos Pérez JJ
Rev Gastroenterol Mex; 1984; 49(3):179-84. PubMed ID: 6151237
[No Abstract] [Full Text] [Related]
7. Ulcer disease of the upper gastrointestinal tract.
Meeroff JC
Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
[No Abstract] [Full Text] [Related]
8. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
9. Duodenal ulcers that are difficult to heal.
Pounder R
BMJ; 1988 Dec; 297(6663):1560-1. PubMed ID: 2906259
[No Abstract] [Full Text] [Related]
10. Response to "H2-receptor antagonists and duodenal ulcer recurrence".
Kurata JH; Nogawa AN; Koch GG
Am J Gastroenterol; 1988 Dec; 83(12):1427-9. PubMed ID: 2904219
[No Abstract] [Full Text] [Related]
11. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist].
Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616
[No Abstract] [Full Text] [Related]
12. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
13. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
Bardhan KD
Am J Gastroenterol; 1994 Jan; 89(1):3-6. PubMed ID: 7903845
[No Abstract] [Full Text] [Related]
14. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
de Bruijne JW; Lamers CB
Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
[No Abstract] [Full Text] [Related]
15. The assessment and management of peptic ulcer.
Gibbs D
Br J Hosp Med; 1981 Mar; 25(3):278, 280, 282-3. PubMed ID: 6111368
[No Abstract] [Full Text] [Related]
16. [Changes in the surgical directions in the treatment of gastric and duodenal ulcers].
Pietri P; Gabrielli F
Minerva Chir; 1985 Jan 15-31; 40(1-2):33-44. PubMed ID: 3887216
[No Abstract] [Full Text] [Related]
17. Bedtime treatment of duodenal ulcer.
Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
[No Abstract] [Full Text] [Related]
18. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
19. H2-receptor antagonists: development and application.
Feldman S
N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
[TBL] [Abstract][Full Text] [Related]
20. [Nocturnal gastric secretion and duodenal ulcer].
Mazure RM; Mazure PA
Acta Gastroenterol Latinoam; 1984; 14(3):243-8. PubMed ID: 6152644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
